XNAS: GRCE
Grace Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Grace Therapeutics Inc is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its development pipeline consists of the following product candidates: GTx-104, a novel injectable formulation of nimodipine for the tr...
Read More
2.46
0.05
(2.07%)
67,830.2
XNAS Volume
XNAS 17 Jul, 2026 2:08 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Grace Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..